Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Gut Microbiota
91%
Inflammatory Bowel Disease
84%
Microbiome
33%
Crohn's Disease
22%
Gut Microbiota Composition
20%
Fecal Samples
20%
Dutch
18%
Host Genetics
16%
Omics Data
15%
Irritable Bowel Syndrome
15%
Comorbidity
14%
Microbiome Study
14%
Metabolic Potential
13%
Microbial Pathways
13%
Environmental Factors
11%
Chronic Inflammatory Diseases
11%
Composition Function
10%
Clinical Application
10%
Metabolic Function
10%
Disease-specific
9%
Stool Samples
9%
Gut Bacterial Community
8%
Dietary Patterns
8%
Exposome
8%
Functional Change
7%
Positive Engagement
7%
Composition Change
7%
Disease-based
7%
Pleiotropy
7%
Disease Exacerbation
7%
Specific Pattern
7%
Co-abundance Network
7%
Missense Variant
7%
Drug Repositioning
7%
Shared Loci
7%
SLC39A8
7%
Microbiota Interactions
7%
Genome Analysis
7%
New Association
7%
Patient Attitudes
7%
Defensin
7%
Dutch Population
7%
Risk Spectrum
7%
Clinical Care
7%
Cardiovascular Risk
7%
Fecal Metabolites
7%
Meta-analysis
7%
Fecal Calprotectin
7%
Small Intestinal Microbiome
7%
ST-elevation Myocardial Infarction (STEMI)
7%
Immunology and Microbiology
Gut Microbiome
100%
Inflammatory Bowel Disease
92%
Microbiome
60%
Intestine Flora
38%
Crohn's Disease
27%
Metagenomics
18%
Metabolome
15%
Comorbidity
12%
Inflammatory Disorder
12%
Metagenome
11%
Taxon
10%
Resistome
10%
Dysbiosis
9%
Normal Human
8%
Ulcerative Colitis
8%
Metabolite
8%
Coronary Artery
7%
Pleiotropy
7%
Beta-Defensin 2
7%
Multi-Omics
7%
Solid Organ Transplantation
7%
Cardiovascular System
7%
Inflammation Response
7%
Virulence Factor
6%
Antibiotic Resistance
5%
Small Intestine
5%
Gastrointestinal Tract
5%
Primary Sclerosing Cholangitis
5%
Biosynthesis
5%
Medicine and Dentistry
Inflammatory Bowel Disease
56%
Gut Microbiota
24%
Gut Microbiome
14%
Patient with Inflammatory Bowel Disease
14%
Irritable Bowel Syndrome
13%
Crohn's Disease
10%
Inflammatory Disorder
10%
Diseases
10%
Genetics
9%
Gut
8%
Anti-Inflammatory Drug
7%
Faecal Calprotectin
7%
Drug Repositioning
7%
Beta Defensin 2
7%
Disease Exacerbation
7%
Microflora
7%
Microbiome
7%
Pleiotropy
5%
Comorbidity
5%
Small Intestine
5%
Gastrointestinal Tract
5%